Table 2.
Quality assessment for before-after (pre-post) studies with No control group.
| Study | Q 1 | Q 2 | Q 3 | Q 4 | Q 5 | Q 6 | Q 7 | Q 8 | Q 9 | Q 10 | Q 11 | Q 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blumling, 2018 | Yes | NR | Yes | Yes | No | Yes | Yes | NR | NR | Yes | Yes | NR |
| Kim, 2018 | Yes | Yes | Yes | Yes | NR | Yes | Yes | NR | NR | Yes | NA | NR |
| Lubbers, 2016 | Yes | Yes | Yes | Yes | No | Yes | Yes | NR | NR | NR | NR | NR |
| Saied, 2017 | Yes | Yes | Yes | Yes | No | Yes | Yes | NR | NR | Yes | NR | NR |
| Question 1 | Study question, Was the study question or objective clearly stated? |
|---|---|
| Question 2 | Eligibility criteria and study population |
| Question 3 | Study participants representative of clinical populations of interest |
| Question 4 | All eligible participants enrolled |
| Question 5 | Sample size; Was the sample size sufficiently large to provide confidence in the findings? |
| Question 6 | Intervention clearly described |
| Question 7 | Outcome measures clearly described, valid, and reliable |
| Question 8 | Blinding of outcome assessors |
| Question 9 | Follow-up rate |
| Question 10 | Statistical analysis |
| Question 11 | Multiple outcome measures |
| Question 12 | Group-level interventions and individual-level outcome efforts |
*NA, not applicable; NR, not reported.